Cargando…

PBX3 in Cancer

PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interac...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Richard, Pandha, Hardev S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072649/
https://www.ncbi.nlm.nih.gov/pubmed/32069812
http://dx.doi.org/10.3390/cancers12020431
_version_ 1783506455703322624
author Morgan, Richard
Pandha, Hardev S
author_facet Morgan, Richard
Pandha, Hardev S
author_sort Morgan, Richard
collection PubMed
description PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a therapeutic target.
format Online
Article
Text
id pubmed-7072649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70726492020-03-19 PBX3 in Cancer Morgan, Richard Pandha, Hardev S Cancers (Basel) Review PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a therapeutic target. MDPI 2020-02-13 /pmc/articles/PMC7072649/ /pubmed/32069812 http://dx.doi.org/10.3390/cancers12020431 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Morgan, Richard
Pandha, Hardev S
PBX3 in Cancer
title PBX3 in Cancer
title_full PBX3 in Cancer
title_fullStr PBX3 in Cancer
title_full_unstemmed PBX3 in Cancer
title_short PBX3 in Cancer
title_sort pbx3 in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072649/
https://www.ncbi.nlm.nih.gov/pubmed/32069812
http://dx.doi.org/10.3390/cancers12020431
work_keys_str_mv AT morganrichard pbx3incancer
AT pandhahardevs pbx3incancer